Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Chronic Lymphocytic Leukemia
Related studies linked through entity extraction aliases.
Nemtabrutinib and Venetoclax for the Treatment of Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study on Treatment Outcome Patterns for Patients With CLL After Discontinuation of BTK Inhibitors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
variaTIon in Referral Thresholds in the Chronic Lymphocytic LeukaEmia Pathway
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
This Clinical Trial is a Single-arm, Non-randomized Pilot Trial to Determine the Safety of Administering Autologous Anti-C19 Cells (ARI-0001) and the Feasibility of Local CAR-T Cell Production in Patients Over 18 Years of Age With Relapsed/Refractory (R/R) CD19+ Hematologic Malignancies, Including R
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Observ Prosp Study of Acalabrutinib in CLL Therapy in Real Clinical Practice in Belarus
- Status
- RECRUITING
- Phase
- N/A
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies
- Status
- RECRUITING
- Phase
- PHASE2
Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Status
- RECRUITING
- Phase
- PHASE4
CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1
Study of Epcoritamab as a Consolidation Therapy in CLL/SLL
- Status
- RECRUITING
- Phase
- PHASE2
Determinants of the Response to BTK Degraders (BTKd) in Chronic Lymphocytic Leukemia
- Status
- RECRUITING
- Phase
- N/A
Mosunetuzumab for CLL MRD Clearance
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
- Status
- RECRUITING
- Phase
- PHASE1